Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by David A. Sorrell
Targeting the MAPK Signaling Pathway in Cancer: Promising Preclinical Activity With the Novel Selective ERK1/2 Inhibitor BVD-523 (Ulixertinib)
Molecular Cancer Therapeutics
Cancer Research
Oncology
Related publications
Tribbles 3 Regulates the Fibrosis Cytokine TGF-β1 Through ERK1/2-MAPK Signaling Pathway in Diabetic Nephropathy
Journal of Immunology Research
Medicine
Allergy
Immunology
Targeting the PI3K Signaling Pathway in Cancer
Current Opinion in Genetics and Development
Genetics
Developmental Biology
Targeting the AXL Signaling Pathway in Ovarian Cancer
Molecular and Cellular Oncology
Cancer Research
Molecular Medicine
Identification of a Novel Tumor Angiogenesis Inhibitor Targeting SHH/Gli1 Signaling Pathway in Non-Small Cell Lung Cancer
Cell Death and Disease
Molecular Neuroscience
Immunology
Cell Biology
Cancer Research
Cellular
Medicine
Paeonol Enhances Thrombus Recanalization by Inducing Vascular Endothelial Growth Factor 165 via ERK1/2 MAPK Signaling Pathway
Molecular Medicine Reports
Oncology
Genetics
Molecular Biology
Biochemistry
Cancer Research
Molecular Medicine
CIIA Negatively Regulates the Ras-Erk1/2 Signaling Pathway Through Inhibiting the Ras-Specific GEF Activity of SOS1
Journal of Cell Science
Cell Biology
Acidic Extracellular pH Induces Vascular Endothelial Growth Factor (VEGF) in Human Glioblastoma Cells via ERK1/2 MAPK Signaling Pathway
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
A Novel CYR61-triggered ‘CYR61-αvβ3 Integrin Loop’ Regulates Breast Cancer Cell Survival and Chemosensitivity Through Activation of ERK1/ERK2 MAPK Signaling Pathway
Oncogene
Cancer Research
Genetics
Molecular Biology
Rogaratinib: A Potent and Selective Pan-FGFR Inhibitor With Broad Antitumor Activity in FGFR-overexpressing Preclinical Cancer Models
International Journal of Cancer
Cancer Research
Oncology
